Stock Analysis on Net

UnitedHealth Group Inc. (NYSE:UNH)

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin 
Quarterly Data

Microsoft Excel

Two-Component Disaggregation of ROE

UnitedHealth Group Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = ROA × Financial Leverage
Mar 31, 2026 12.30% = 3.85% × 3.19
Dec 31, 2025 12.81% = 3.89% × 3.29
Sep 30, 2025 18.36% = 5.58% × 3.29
Jun 30, 2025 22.48% = 6.90% × 3.26
Mar 31, 2025 23.26% = 7.14% × 3.26
Dec 31, 2024 15.55% = 4.83% × 3.22
Sep 30, 2024 15.14% = 4.78% × 3.17
Jun 30, 2024 15.78% = 4.93% × 3.20
Mar 31, 2024 17.72% = 5.40% × 3.28
Dec 31, 2023 25.22% = 8.18% × 3.08
Sep 30, 2023 25.67% = 7.69% × 3.34
Jun 30, 2023 25.63% = 7.53% × 3.40
Mar 31, 2023 25.46% = 7.30% × 3.49
Dec 31, 2022 25.87% = 8.19% × 3.16
Sep 30, 2022 26.03% = 7.99% × 3.26
Jun 30, 2022 25.07% = 7.93% × 3.16
Mar 31, 2022 23.98% = 7.89% × 3.04

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The Return on Equity (ROE) experienced a period of notable instability between March 2022 and March 2026. After maintaining levels above 25% for most of 2022 and 2023, ROE underwent a sharp contraction in 2024, followed by a temporary recovery in early 2025 and a subsequent decline toward the end of the analyzed period.

Return on Assets (ROA)
Asset productivity served as the primary driver of volatility. ROA remained relatively stable and peaked at 8.19% in December 2022. A significant downward trend began in early 2024, with the ratio falling to 4.78% by September 2024. Although a recovery to 7.14% occurred in March 2025, a consistent decline followed, resulting in a period low of 3.85% by March 2026.
Financial Leverage
The leverage ratio remained comparatively stable throughout the observed timeframe, oscillating between a low of 3.04 in March 2022 and a peak of 3.49 in March 2023. This stability indicates a consistent capital structure, suggesting that the company did not utilize increased financial gearing to offset declines in asset performance.
ROE Disaggregation Analysis
The two-component analysis reveals that fluctuations in ROE were almost exclusively driven by changes in ROA. The contraction of ROE from 25.22% in December 2023 to 15.14% in September 2024 directly corresponds to the compression in asset returns during the same interval. Similarly, the final descent of ROE to 12.30% in March 2026 mirrors the steady degradation of the ROA component.

AI Ask an analyst for more


Three-Component Disaggregation of ROE

UnitedHealth Group Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Mar 31, 2026 12.30% = 2.70% × 1.43 × 3.19
Dec 31, 2025 12.81% = 2.72% × 1.43 × 3.29
Sep 30, 2025 18.36% = 4.09% × 1.36 × 3.29
Jun 30, 2025 22.48% = 5.10% × 1.35 × 3.26
Mar 31, 2025 23.26% = 5.46% × 1.31 × 3.26
Dec 31, 2024 15.55% = 3.65% × 1.32 × 3.22
Sep 30, 2024 15.14% = 3.68% × 1.30 × 3.17
Jun 30, 2024 15.78% = 3.70% × 1.33 × 3.20
Mar 31, 2024 17.72% = 4.09% × 1.32 × 3.28
Dec 31, 2023 25.22% = 6.09% × 1.34 × 3.08
Sep 30, 2023 25.67% = 6.09% × 1.26 × 3.34
Jun 30, 2023 25.63% = 6.11% × 1.23 × 3.40
Mar 31, 2023 25.46% = 6.21% × 1.18 × 3.49
Dec 31, 2022 25.87% = 6.25% × 1.31 × 3.16
Sep 30, 2022 26.03% = 6.21% × 1.29 × 3.26
Jun 30, 2022 25.07% = 5.99% × 1.32 × 3.16
Mar 31, 2022 23.98% = 5.91% × 1.33 × 3.04

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The Return on Equity (ROE) exhibits significant volatility over the analyzed period, characterized by a period of stability followed by two distinct cycles of contraction and partial recovery. From March 2022 through December 2023, ROE remained consistently high, peaking at 26.03% in September 2022. However, a sharp decline occurred in early 2024, with ROE dropping to 15.14% by September 2024, before experiencing a temporary rebound in the first half of 2025. A subsequent and more severe downward trend is observed from June 2025 to March 2026, where ROE fell to a period low of 12.30%.

Net Profit Margin
Profitability serves as the primary driver of the observed fluctuations in ROE. The margin remained stable between 5.91% and 6.25% through 2022 and 2023. A substantial contraction began in March 2024, where the margin dropped to 4.09%, reaching a low of 3.65% by December 2024. While a recovery occurred in March 2025 (5.46%), a steep decline followed, ending at 2.70% in March 2026. This consistent erosion of profit margins directly correlates with the overall decline in equity returns.
Asset Turnover
Asset utilization has remained relatively stable and showed a slight positive trajectory over the long term. The ratio fluctuated minimally between 1.18 and 1.34 during the first two years. Notably, from December 2024 onward, a gradual increase is observed, peaking at 1.43 in the final two quarters. This suggests that operational efficiency in generating revenue from assets improved even as profitability declined, though these gains were insufficient to offset the margin compression.
Financial Leverage
The leverage ratio acted as a consistent multiplier throughout the period, generally fluctuating between 3.04 and 3.49. A peak in leverage was noted in March 2023 at 3.49, followed by a period of relative stability around the 3.20 range. Because the leverage ratio did not experience drastic shifts, it is concluded that the volatility in ROE was not caused by changes in the capital structure or debt levels, but rather by the underlying performance of the income statement.

The DuPont disaggregation reveals that the deterioration of ROE is exclusively attributable to the contraction of the Net Profit Margin. The stability of Financial Leverage and the marginal improvement in Asset Turnover indicate that the company's financial structure and asset efficiency remained intact. The overall decline in shareholder returns is therefore driven by a systemic reduction in profitability per dollar of revenue.

AI Ask an analyst for more


Five-Component Disaggregation of ROE

UnitedHealth Group Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Mar 31, 2026 12.30% = 0.87 × 0.78 × 3.98% × 1.43 × 3.19
Dec 31, 2025 12.81% = 0.86 × 0.78 × 4.05% × 1.43 × 3.29
Sep 30, 2025 18.36% = 0.82 × 0.84 × 5.92% × 1.36 × 3.29
Jun 30, 2025 22.48% = 0.83 × 0.86 × 7.16% × 1.35 × 3.26
Mar 31, 2025 23.26% = 0.81 × 0.87 × 7.76% × 1.31 × 3.26
Dec 31, 2024 15.55% = 0.75 × 0.83 × 5.86% × 1.32 × 3.22
Sep 30, 2024 15.14% = 0.74 × 0.84 × 5.93% × 1.30 × 3.17
Jun 30, 2024 15.78% = 0.73 × 0.85 × 6.01% × 1.33 × 3.20
Mar 31, 2024 17.72% = 0.73 × 0.86 × 6.48% × 1.32 × 3.28
Dec 31, 2023 25.22% = 0.79 × 0.90 × 8.60% × 1.34 × 3.08
Sep 30, 2023 25.67% = 0.78 × 0.90 × 8.67% × 1.26 × 3.34
Jun 30, 2023 25.63% = 0.78 × 0.91 × 8.66% × 1.23 × 3.40
Mar 31, 2023 25.46% = 0.78 × 0.92 × 8.70% × 1.18 × 3.49
Dec 31, 2022 25.87% = 0.78 × 0.93 × 8.67% × 1.31 × 3.16
Sep 30, 2022 26.03% = 0.79 × 0.93 × 8.49% × 1.29 × 3.26
Jun 30, 2022 25.07% = 0.79 × 0.93 × 8.16% × 1.32 × 3.16
Mar 31, 2022 23.98% = 0.79 × 0.93 × 8.04% × 1.33 × 3.04

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The analysis of the five-component DuPont disaggregation reveals a significant deterioration in Return on Equity (ROE) over the observed period. ROE peaked at 26.03% in September 2022 and remained relatively stable through 2023 before experiencing a sharp contraction. While a brief recovery occurred in early 2025, the metric declined steeply to 12.30% by March 2026, representing a substantial reduction in the efficiency of generating shareholder returns.

EBIT Margin
The EBIT margin serves as the primary driver for the decline in ROE. After maintaining a stable range between 8.04% and 8.70% from March 2022 through December 2023, the margin entered a period of high volatility. A significant drop was observed in 2024, reaching a low of 5.86% by December. Despite a momentary surge to 7.76% in March 2025, the margin collapsed further to 3.98% by March 2026, indicating a severe compression in operational profitability.
Tax Burden
The tax burden ratio remained consistent near 0.79 for much of 2022 and 2023. A temporary dip to 0.73 occurred in early 2024, followed by a steady upward trend, reaching 0.87 by March 2026. This increase suggests a lower effective tax rate relative to pre-tax income, which acted as a partial mitigate to the falling ROE.
Interest Burden
The interest burden ratio exhibited a gradual downward trend. From a peak of 0.93 in 2022, the ratio declined to 0.83 by December 2024. Although it stabilized briefly in early 2025, it fell to 0.78 by March 2026, indicating that interest expenses consumed a larger portion of operating income over time.
Asset Turnover
Asset turnover demonstrated relative stability with a slight positive trajectory toward the end of the period. While values fluctuated between 1.18 and 1.34 through 2023 and 2024, the ratio climbed to 1.43 by December 2025 and March 2026. This suggests an improvement in the efficiency of asset utilization to generate revenue, though this gain was insufficient to offset the margin decline.
Financial Leverage
Financial leverage remained relatively constant, fluctuating within a range of 3.04 to 3.49. There is no evidence of a strategic shift in the capital structure to amplify returns, as the ratio ended the period at 3.19, close to its initial 2022 levels.

In summary, the collapse in ROE is almost exclusively attributable to the degradation of the EBIT margin, which halved over the period. The operational decline was exacerbated by a weakening interest burden. These negative pressures outweighed the marginal benefits gained from improved asset turnover and a more favorable tax burden ratio.

AI Ask an analyst for more


Two-Component Disaggregation of ROA

UnitedHealth Group Inc., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Mar 31, 2026 3.85% = 2.70% × 1.43
Dec 31, 2025 3.89% = 2.72% × 1.43
Sep 30, 2025 5.58% = 4.09% × 1.36
Jun 30, 2025 6.90% = 5.10% × 1.35
Mar 31, 2025 7.14% = 5.46% × 1.31
Dec 31, 2024 4.83% = 3.65% × 1.32
Sep 30, 2024 4.78% = 3.68% × 1.30
Jun 30, 2024 4.93% = 3.70% × 1.33
Mar 31, 2024 5.40% = 4.09% × 1.32
Dec 31, 2023 8.18% = 6.09% × 1.34
Sep 30, 2023 7.69% = 6.09% × 1.26
Jun 30, 2023 7.53% = 6.11% × 1.23
Mar 31, 2023 7.30% = 6.21% × 1.18
Dec 31, 2022 8.19% = 6.25% × 1.31
Sep 30, 2022 7.99% = 6.21% × 1.29
Jun 30, 2022 7.93% = 5.99% × 1.32
Mar 31, 2022 7.89% = 5.91% × 1.33

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The Return on Assets (ROA) exhibits a volatile trajectory characterized by an initial period of stability followed by a significant long-term decline. After peaking at 8.19% in December 2022 and returning to 8.18% in December 2023, the ROA entered a downward trend, reaching a period low of 3.85% by March 2026.

Net Profit Margin
A contraction in profitability serves as the primary driver of the diminishing ROA. Margins remained consistent, fluctuating between 5.91% and 6.25% through 2022 and 2023, but experienced a sharp decline starting in March 2024, dropping to 3.65% by the end of that year. Despite a brief recovery to 5.46% in March 2025, the margin continued a steep descent, closing at 2.70% in March 2026.
Asset Turnover
Efficiency in asset utilization remained relatively stable throughout the analyzed period. Asset turnover fluctuated within a narrow range, primarily between 1.18 and 1.34 from 2022 through 2024. Notably, asset turnover improved toward the end of the series, increasing to 1.43 by December 2025 and March 2026, suggesting that operational efficiency increased even as profitability declined.
ROA Component Synthesis
The disaggregation of ROA reveals a clear divergence between efficiency and profitability. The overall decline in ROA is attributable to the erosion of net profit margins rather than a failure in asset management. The increase in asset turnover during the final quarters indicates that the organization improved its ability to generate revenue from its asset base, yet this improvement was insufficient to offset the significant compression in net profit margins.

AI Ask an analyst for more


Four-Component Disaggregation of ROA

UnitedHealth Group Inc., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Mar 31, 2026 3.85% = 0.87 × 0.78 × 3.98% × 1.43
Dec 31, 2025 3.89% = 0.86 × 0.78 × 4.05% × 1.43
Sep 30, 2025 5.58% = 0.82 × 0.84 × 5.92% × 1.36
Jun 30, 2025 6.90% = 0.83 × 0.86 × 7.16% × 1.35
Mar 31, 2025 7.14% = 0.81 × 0.87 × 7.76% × 1.31
Dec 31, 2024 4.83% = 0.75 × 0.83 × 5.86% × 1.32
Sep 30, 2024 4.78% = 0.74 × 0.84 × 5.93% × 1.30
Jun 30, 2024 4.93% = 0.73 × 0.85 × 6.01% × 1.33
Mar 31, 2024 5.40% = 0.73 × 0.86 × 6.48% × 1.32
Dec 31, 2023 8.18% = 0.79 × 0.90 × 8.60% × 1.34
Sep 30, 2023 7.69% = 0.78 × 0.90 × 8.67% × 1.26
Jun 30, 2023 7.53% = 0.78 × 0.91 × 8.66% × 1.23
Mar 31, 2023 7.30% = 0.78 × 0.92 × 8.70% × 1.18
Dec 31, 2022 8.19% = 0.78 × 0.93 × 8.67% × 1.31
Sep 30, 2022 7.99% = 0.79 × 0.93 × 8.49% × 1.29
Jun 30, 2022 7.93% = 0.79 × 0.93 × 8.16% × 1.32
Mar 31, 2022 7.89% = 0.79 × 0.93 × 8.04% × 1.33

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The analysis of the Return on Assets (ROA) reveals a significant long-term decline, transitioning from a period of relative stability and peak performance between 2022 and 2023 to a marked contraction by early 2026. While ROA remained robustly above 7.5% for much of the first two years, it experienced a sharp decline starting in 2024, eventually reaching a low of 3.85% by March 31, 2026.

Operating Profitability (EBIT Margin)
The EBIT margin serves as the primary driver for the deterioration in ROA. After maintaining a peak range of 8.04% to 8.70% through December 2023, the margin entered a period of volatility and contraction. A notable decline occurred throughout 2024, with the margin dropping to 5.86% by year-end. Despite a brief recovery to 7.76% in March 2025, a steep downward trend followed, culminating in a period low of 3.98% in March 2026. This compression indicates a substantial increase in operating expenses or a decrease in pricing power relative to revenue.
Asset Utilization (Asset Turnover)
In contrast to profitability metrics, asset turnover demonstrated resilience and a general upward trend. The ratio fluctuated between 1.18 and 1.43, ending the period at its highest level of 1.43. This suggests that the decline in ROA was not caused by a failure to generate revenue from the asset base; rather, the company increased its asset efficiency even as its operating margins collapsed.
Financial and Tax Burdens
The interest burden shows a consistent downward trajectory, moving from 0.93 in early 2022 to 0.78 by March 2026. This decrease indicates that interest expenses consumed a larger portion of operating income over time, exerting additional downward pressure on net profitability. Conversely, the tax burden ratio improved toward the end of the period, rising from a low of 0.73 in early 2024 to 0.87 by March 2026, suggesting a lower effective tax rate that partially mitigated the losses from operating and interest burdens.

Overall, the disaggregation of ROA indicates a fundamental shift in the company's performance profile. The gains achieved through improved asset turnover and a more favorable tax position were insufficient to offset the severe compression of the EBIT margin and the increasing weight of interest obligations.

AI Ask an analyst for more


Disaggregation of Net Profit Margin

UnitedHealth Group Inc., decomposition of net profit margin ratio (quarterly data)

Microsoft Excel
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Mar 31, 2026 2.70% = 0.87 × 0.78 × 3.98%
Dec 31, 2025 2.72% = 0.86 × 0.78 × 4.05%
Sep 30, 2025 4.09% = 0.82 × 0.84 × 5.92%
Jun 30, 2025 5.10% = 0.83 × 0.86 × 7.16%
Mar 31, 2025 5.46% = 0.81 × 0.87 × 7.76%
Dec 31, 2024 3.65% = 0.75 × 0.83 × 5.86%
Sep 30, 2024 3.68% = 0.74 × 0.84 × 5.93%
Jun 30, 2024 3.70% = 0.73 × 0.85 × 6.01%
Mar 31, 2024 4.09% = 0.73 × 0.86 × 6.48%
Dec 31, 2023 6.09% = 0.79 × 0.90 × 8.60%
Sep 30, 2023 6.09% = 0.78 × 0.90 × 8.67%
Jun 30, 2023 6.11% = 0.78 × 0.91 × 8.66%
Mar 31, 2023 6.21% = 0.78 × 0.92 × 8.70%
Dec 31, 2022 6.25% = 0.78 × 0.93 × 8.67%
Sep 30, 2022 6.21% = 0.79 × 0.93 × 8.49%
Jun 30, 2022 5.99% = 0.79 × 0.93 × 8.16%
Mar 31, 2022 5.91% = 0.79 × 0.93 × 8.04%

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The net profit margin exhibited a period of relative stability from early 2022 through late 2023, fluctuating within a narrow range between 5.91% and 6.25%. However, a significant transition occurred starting in early 2024, marked by a sharp contraction in profitability. While a temporary recovery was observed in the first quarter of 2025, reaching 5.46%, the margin entered a steep decline thereafter, reaching a period low of 2.70% by March 31, 2026.

Operating Efficiency (EBIT Margin)
The EBIT margin served as the primary driver of overall profitability volatility. Between March 2022 and December 2023, operating efficiency improved slightly, peaking at 8.70%. This stability was interrupted in early 2024 with a precipitous drop to 6.48%, continuing a downward trajectory to 5.86% by year-end. Although a brief resurgence to 7.76% occurred in March 2025, the margin collapsed severely in the following quarters, ending at 3.98% in March 2026, indicating a substantial increase in operating costs or a decrease in core operational revenue efficiency.
Financial Leverage Impact (Interest Burden)
The interest burden remained consistently high and stable above 0.90 through 2023, suggesting minimal impact from interest expenses on the net margin. A gradual erosion began in 2024, with the ratio falling to 0.83 by December. A subsequent recovery to 0.87 in early 2025 was short-lived, as the ratio declined sharply to 0.78 by late 2025 and early 2026. This trend indicates that rising interest costs became a more significant drag on net profitability toward the end of the analyzed period.
Fiscal Efficiency (Tax Burden)
The tax burden remained largely stagnant near 0.78 to 0.79 during the 2022-2023 period. A dip to 0.73 in early 2024 coincided with the initial drop in net profit margin. Notably, the tax burden trended upward from March 2025 (0.81) to March 2026 (0.87). This increase suggests improved tax efficiency or a lower effective tax rate, which acted as a partial buffer against the simultaneous deterioration of the EBIT margin and interest burden.

The disaggregation of the net profit margin reveals that the overarching decline in profitability is primarily attributed to a severe collapse in operating margins (EBIT), further exacerbated by increasing interest expenses. The improvement in the tax burden was insufficient to offset these operational and financial headwinds, resulting in a significant overall compression of the net profit margin by early 2026.

AI Ask an analyst for more